Applied Therapeutics, Inc. (NASDAQ: APLT) related to its sale to Cycle Group Holdings Limited. Under the terms of the proposed transaction, Applied shareholders are expected to receive $0.088 per share in cash plus one non-transferrable contingent value right entitling the holder to receive potential additional payments under certain conditions.